Who is sponsoring NCT02834156?

NCT02834156 is sponsored by Centre Hospitalier Universitaire de Nice.

What drugs are being tested in NCT02834156?

Interventions in NCT02834156: LP in a seated position then LP in a lying position, LP in a lying position then LP in a seated position.

What condition does NCT02834156 study?

NCT02834156 studies Hematological Malignancies.

Is NCT02834156 still recruiting?

NCT02834156 is currently completed. Last updated 12 March 2018.

Last reviewed 2018-03-12 · How we verify

NCT02834156: PHIPA-PEPL

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Child Positioning on Pain During a Lumbar Puncture

Completed NA Last updated 12 March 2018

What this trial tests

NA trial testing LP in a seated position then LP in a lying position in Hematological Malignancies in 28 participants. Completed in 23 August 2017.

Timeline

30 June 2015

Primary endpoint
23 August 2017

23 August 2017

Quick facts

Lead sponsor	Centre Hospitalier Universitaire de Nice
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	other
Enrollment	28
Start date	30 June 2015
Primary completion	23 August 2017
Estimated completion	23 August 2017
Sites	1 location across France

Drugs / interventions tested

LP in a seated position then LP in a lying position
LP in a lying position then LP in a seated position

Conditions studied

Hematological Malignancies — all drugs for Hematological Malignancies →

Sponsor

Centre Hospitalier Universitaire de Nice

Who can join

Adults 2 to 18, any sex, with Hematological Malignancies. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This protocol is a pilot study on standard care. The main goal is to assess the impact of positioning on lumbar puncture process especially on pain sensitivity in children. It's a prospective, monocentric, randomized, open-label, cross-over study. Inclusion period is one year, and number of inclusions forecasted is about 30. Each patient will have one LP in a seated position and one in a lying position.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Positioning for lumbar puncture in newborn infants.
Pessano S, Bruschettini M, Prescott MG, Romantsik O. · · 2023 · cited 2× · PMID 38096386 · DOI 10.1002/14651858.cd015592.pub3
Positioning for lumbar puncture in newborn infants.
Pessano S, Bruschettini M, Prescott MG, Romantsik O. · · 2023 · cited 2× · PMID 37870133 · DOI 10.1002/14651858.cd015592.pub2

Verify or expand the search:

Other recruiting trials for Hematological Malignancies

Currently open trials in the same condition.

NCT07220616 — A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies · Phase 1, PHASE2 · recruiting
NCT06584955 — Feasibility of the Use of Weighted Blankets to Improve Sleep Among Patients With Hematological Malignancies · NA · active not recruiting
NCT06387082 — A Clinical Study of HMPL-506 in Patients With Hematological Malignancies · Phase 1 · recruiting
NCT06150469 — Efficacy of Inhaled Aromatherapy on Nausea and Vomiting in Hematological Malignancies · NA · recruiting
NCT06179511 — Study of AZD9829 in CD123+ Hematological Malignancies · Phase 1, PHASE2 · active not recruiting

Other Centre Hospitalier Universitaire de Nice trials

Trials by the same sponsor.

NCT05897996 — Percutaneous Anastomosis Creation for Hemodialysis Access · NA · withdrawn
NCT07499869 — INNOVATIVE BENEFITS OF A 4D VIRTUAL SIMULATOR · NA · not yet recruiting
NCT07492251 — Upadacitinib in Adult Patients With Erosive Mucosal Lichen Planus and Lichen Planopilaris: a Prospective Multicenter Ran · Phase 2 · not yet recruiting
NCT07511608 — Development of a New Technique for Quantifying Mitochondrial DNA in Single Muscle Fibers · NA · not yet recruiting
NCT07582406 — Codesign, Physical Activity, and Seniors · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02834156 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de Nice
Last refreshed: 12 March 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02834156.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing